NCT03089697 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Etienne J, Fleurette J, Ninet JF, Favet P, Gruer LD
Staphylococcal endocarditis after dental extraction. Lancet. 1986 Aug 30;2(8505):511-2.
Kundsin RB
Documentation of airborne infection during surgery. Ann N Y Acad Sci. 1980;353:255-61.
Lamy B, Dargère S, Arendrup MC, Parienti JJ, Tattevin P
How to Optimize the Use of Blood Cultures for the Diagnosis of Bloodstream Infections? A State-of-the Art. Front Microbiol. 2016 May 12;7:697. doi: 10.3389/fmicb.2016.00697. eCollection 2016. Review
van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB
Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev. 2012 Apr;25(2):362-86. doi: 10.1128/CMR.05022-11. Review.

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase IIa Clinical Study to Evaluate Safety and to Explore Efficacy of N-Rephasin® SAL200, in Patients With Persistent Staphylococcus Aureus Bacteremia

Details for clinical trial NCT03089697

Clinical trial NCT03089697 - References